Video

Inside the complex, surprising world of MS comorbidities

Publish date: May 31, 2018

 

EXPERT ANALYSIS FROM THE CMSC ANNUAL MEETING


Other research coauthored by Dr. Tremlett has linked comorbidities in MS – specifically, hyperlipidemia, migraine, and three or more comorbidities – to higher risk of MS relapse (Neurology. 2017 Dec 12;89[24]:2455-61).

Dr. Tremlett reported having no relevant disclosures.

Pages

Recommended Reading

Interim Results Show Efficacy for a Novel MS Drug
ICYMI Multiple Sclerosis
Ocrelizumab safety update: Encouraging rates of serious infection, malignancy
ICYMI Multiple Sclerosis
Wide variety of MS topics on tap at CMSC 2018
ICYMI Multiple Sclerosis
Rehabilitation in MS is hot topic at CMSC 2018
ICYMI Multiple Sclerosis
CMSC looks to increase advocacy efforts to address looming concerns
ICYMI Multiple Sclerosis
DMTs Are Associated With Reduced Stroke Risk in Patients With MS
ICYMI Multiple Sclerosis
AAN Publishes Practice Guideline on DMTs for MS
ICYMI Multiple Sclerosis
Do Cardiovascular Risk Factors Contribute to Brain Atrophy in MS?
ICYMI Multiple Sclerosis
iPad app puts cognitive screening in the hands of MS patients
ICYMI Multiple Sclerosis
Value-based care spawns new challenges for MS physicians
ICYMI Multiple Sclerosis